Industry Policy Committee

Purpose: 

To promote initiatives (outside regulatory and reimbursement) which impact on industry development and sustainability and healthcare policy. 

Objectives: 

  1. Develop policy positions and engage with stakeholders on the following:  
  • Digital healthcare agenda including cybersecurity, the electronic patient record, mobile healthcare and registries.
  • Supply chain issues, including traceability of medical devices, and regularly engaged with GS1 Australia. 
  • MTP Connect initiatives, R&D, clinical trials and commercialisation. 
  • Industry input into NSW Knowledge Hub projects to support the MedTech sector. 
  • Industry input into export initiatives and issues. 
  1. Monitor the implementation of the $30 million grant for SMEs under the MTAA‐Government Agreement. 

MTAA Lead: Paul Dale, Director, Policy

Member Name

Position

Company

Kirk Kikirekov (Chair)Managing Directorh-trak
Mahiyar Hira (Vice Chair)Head of OperationsKarl Storz Australia
Michael Baulch (Board Sponsor)Manager Director ANZBoston Scientific
Rebecca Cortiula (Board Member)Senior Managing DirectorVarian Medical Systems Australasia
Michael ReynoldsDirector Healthcare Economics & AdvocacyBIOTRONIK Australia
Alessandra DoolanPrincipal / DirectorHealth and Technology Advisory Group (HTAG)
Tansy MichaelSenior Business ManagerFresenius Medical Care Australia
Darin KottegeSenior Manager, Government Affairs & PolicyJohnson & Johnson Medical
Stuart HayesBusiness Unit Director Bard Australia
Nicola McNeilState Government Business ManagerStryker 
Con ConstantinouNational Sales ManagerGetz Healthcare
Gabrielle ChallisSenior specialist - Healthcare economics, policy & reimbursementMedtronic Australasia
Neroli ManningSales Director ANZCardinal Health Australia 503
Jeroen MangelmansNational Customer Engagement ManagerLinfox
Michael GardnerVice President, Life Sciences & Healthcare DHL Supply Chain (Australia)